FabRx Turns to SLS 3D Printing Technology for More Effective Customized Medicine Production

Share this Article

3D printed pills are still something that make a lot of people raise their eyebrows; compared to other medical applications, they’re not quite as common or well-known yet. There are plenty of reasons why 3D printing medications is a great idea, however. The technology can create personalized pills, with the exact dosage of every medication a patient needs built right into a single tablet. In addition, 3D printing can create things like special fast-dissolving pills for people who have difficulty swallowing regular pills, and others that control active ingredient release timing. Benefits like these can increase patient compliance by eliminating all difficulty in taking medications, and thus lead to better health.

Put like that, 3D printed medications would seem like a no-brainer, though there are still only a few companies pursuing the technology at the moment. One of those companies is FabRx, a spinoff of University College London’s School of Pharmacy. FabRx is the creator of Printlets, 3D printed tablets with customized dosages of medication. The company had been 3D printing its pills using three technologies: FDM, SLA, and gel/paste extrusion. SLA, however, hasn’t been a viable means of production yet as the materials used in the technology are not GRAS (Generally Recognized As Safe) approved by the FDA.

Now FabRx has started creating its tablets with Selective Laser Sintering, or SLS, technology as well. In a study entitled “Selective laser sintering (SLS) 3D printing of medicines,” which you can access here, the FabRx team describes how they mixed acetaminophen with two pharmaceutical-grade polymers, one with immediate release and one with modified release characteristics. The powders were 3D printed into tablet form using a Sintratec 3D printer.

“In FabRx we are developing business opportunities for the technologies we know, but innovation is a must, we are a research driven company. We wanted to evaluate other 3DP technologies that could work to print medicines. SLS was potentially the best one, because we could use pharmaceutical grade excipients as ink and get the medicine prepared fast by the effect of the laser,” Dr. Alvaro Goyanes Goyanes, FabRX Director of Development, told 3DPrint.com.

“At the beginning, we had no access to SLS printers, and the SLS equipment was very expensive (there were only industrial SLS printers). We did not want to invest a huge amount of money in an equipment that we did not know if it was going to work for printing medicines. Later, we found the Sintratec printer that had the same cost of a high end FDM printer and decided to buy one. We were surprised how easy was to print tablets using pharmaceutical grade polymers (improvement compared to SLA) without the need to get an extruded filament (previous step in FDM). It works better than we expected for such a cheap kit, we recently bought another printer. We are evaluating different excipients and drugs.”

FabRx found that the medications it printed using SLS technology were high resolution and had no drug degradation. The technology makes it possible to 3D print almost any combination of drugs in a variety of shapes, sizes, colors and flavors to make them more appealing to patients, particularly children and the elderly. The Printlets were tested for their drug release capabilities in a Dynamic Dissolution model that modulates pH over time, simulating gastrointestinal conditions. Depending on which excipients are used, the Printlets can be formulated to be immediate release or delayed release.

The efficacy of SLS for 3D printing medications is an exciting discovery for FabRx, but the company isn’t stopping there. Future plans include experimentation with other 3D printing methods, Dr. Goyanes told us, as well as the development of their own 3D printer.

“SLS is only one of our lines of research and work, but we are evaluating and developing all the technologies together,” he told 3DPrint.com. “We are going to start a crowdfunding campaign next month to take to the market a 3D printer specially designed to print oral medicines, because there is no printer specially designed for medicines.”

Authors of the study include Fabrizio Fina, Alvaro Goyanes, Simon Gaisford, and Abdul W. Basit. Discuss in the FabRx forum at 3DPB.com.

Schematic representation of the SLS 3D printer [Image: Fabrizio Fina]

Share this Article


Recent News

Nexa3D Acquires NXT Factory, Introduces Eco-Friendly 3D Printing Washing Solvent

RENA Acquires HES Hirtisation Segment for Post-Processing for Metal 3D Printing



Categories

3D Design

3D Printed Art

3D printed automobiles

3D Printed Food


You May Also Like

NTU Singapore: Robotic Post-Processing System Removes Residual Powder from 3D Printed Parts

Researchers from Nanyang Technological University in Singapore wrote a paper, titled “Development of a Robotic System for Automated Decaking of 3D-Printed Parts,” about their work attempting to circumvent a significant...

Comparing Surface Finish and Post-Processing Methods for SLM 3D Printed Parts

It’s not easy to produce parts that contain internal cooling channels using traditional manufacturing methods, which makes 3D printing an attractive option for easy, precise integration of these channels –...

Dental College of Georgia: Examining Photoinitiator Types in 3D Printing Resins

Researchers from the Dental College of Georgia, Augusta University, are exploring better ways to perform dental restoration, detailing their findings in the recently published ‘Photoinitiator Types Among a Variety of...

Align Technology Acquires exocad, Dental CAD/CAM Software Vendor in €376 Million Deal

Align Technology acquires Global Dental CAD/CAM software firm, exocad. Known for their dental CAD/CAM solutions, exocad will strengthen Align’s presence among dentists, labs, and partners around the globe. The two...


Shop

View our broad assortment of in house and third party products.